Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.925 | 0.080 | 14 | 80201929 | 3 prime UTR variant | C/T | snv | 0.13 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 14 | 80201929 | 3 prime UTR variant | C/T | snv | 0.13 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 14 | 80200883 | 3 prime UTR variant | A/T | snv | 0.58 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 14 | 80200883 | 3 prime UTR variant | A/T | snv | 0.58 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 14 | 80211468 | missense variant | C/T | snv | 1.4E-05 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.790 | 0.200 | 14 | 80211923 | 5 prime UTR variant | C/A;G;T | snv |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.695 | 0.400 | 14 | 80203237 | missense variant | T/C | snv | 0.41 | 0.39 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.882 | 0.160 | 14 | 80201236 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 14 | 80201236 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 14 | 80201236 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.160 | 14 | 80207471 | intron variant | A/G | snv | 0.20 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.160 | 14 | 80207471 | intron variant | A/G | snv | 0.20 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.200 | 14 | 80211923 | 5 prime UTR variant | C/A;G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.200 | 14 | 80211923 | 5 prime UTR variant | C/A;G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.200 | 14 | 80211923 | 5 prime UTR variant | C/A;G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.790 | 0.200 | 14 | 80211923 | 5 prime UTR variant | C/A;G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 |